Evaluation of expert rules for carbapenemase class identification in <i>Enterobacterales</i> isolates using the VITEK2 susceptibility testing platform
Carbapenem-resistant bacteria are a major public health concern due to their ability to spread in healthcare settings and cause infections that are difficult to treat with first-line antibiotics. Identification of the enzyme classes responsible for carbapenem resistance plays a crucial role in ensuring that patients receive effective treatments and controlling the spread of these bacteria. In this study, we evaluated the performance of a new approach to identify carbapenemase enzymes without additional hands-on testing. The method is designed for use with the VITEK2 automated susceptibility testing platform to recognize patterns of resistance to antibiotics and make predictions about the possible resistance mechanisms.
Authors
- Rebekah E. Dumm (ORCID: https://orcid.org/0000-0003-3139-3153)
- Michaela J. Eickhoff (ORCID: https://orcid.org/0000-0003-2376-9237)
- Carol E. Muenks (ORCID: https://orcid.org/0000-0003-4294-8134)
- Murad Ali (ORCID: https://orcid.org/0000-0003-2312-8843)
- Megan L. Porter (ORCID: https://orcid.org/0000-0001-7985-2887)
- Melanie L. Yarbrough (ORCID: https://orcid.org/0000-0003-2166-7552)
- Tahir Hussain (ORCID: https://orcid.org/0000-0003-4143-5660)
- Ikram Uddin
- Abigail P. Brown
Institutions
- Abdul Wali Khan University Mardan (PK)
- Washington University in St. Louis (US)
Publication Details
- Journal
- Journal of Clinical Microbiology
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1128/jcm.00769-25
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00